Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
90.91B | 89.36B | 88.65B | 86.98B | 75.60B | 74.74B | Gross Profit |
24.15B | 23.81B | 23.77B | 23.30B | 20.68B | 20.68B | EBIT |
2.86B | 2.78B | 2.85B | 3.77B | 3.32B | 2.19B | EBITDA |
6.68B | 6.71B | 6.50B | 7.27B | 6.34B | 5.06B | Net Income Common Stockholders |
1.80B | 1.76B | 1.87B | 2.55B | 2.25B | 1.40B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.12B | 6.45B | 3.48B | 3.40B | 3.27B | 3.21B | Total Assets |
51.48B | 51.84B | 47.82B | 48.55B | 45.71B | 40.69B | Total Debt |
4.71B | 20.32B | 17.77B | 17.64B | 17.09B | 14.55B | Net Debt |
-7.00M | 14.16B | 14.29B | 14.59B | 14.12B | 11.64B | Total Liabilities |
36.06B | 36.39B | 33.07B | 33.15B | 31.99B | 28.26B | Stockholders Equity |
15.43B | 15.45B | 14.76B | 15.40B | 13.72B | 12.43B |
Cash Flow | Free Cash Flow | ||||
3.95B | 6.22B | 3.99B | 3.62B | 3.10B | 3.68B | Operating Cash Flow |
6.30B | 6.22B | 6.47B | 6.11B | 5.47B | 6.34B | Investing Cash Flow |
-3.26B | -1.73B | -2.21B | -2.01B | -2.63B | -2.48B | Financing Cash Flow |
-4.85B | -1.98B | -3.78B | -4.19B | -3.05B | -4.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $36.69B | 19.78 | 11.68% | 3.67% | 1.39% | 1.04% | |
70 Outperform | $15.71B | 36.29 | 35.74% | ― | 15.51% | 53.77% | |
69 Neutral | $43.95B | 17.97 | 26.59% | 1.94% | -1.94% | 23.94% | |
67 Neutral | $12.39B | 13.11 | 31.26% | 2.79% | 1.46% | -26.54% | |
65 Neutral | $8.77B | 15.11 | 4.67% | 3.71% | 3.60% | -2.96% | |
64 Neutral | $2.01B | 18.70 | 7.54% | 1.82% | 1.76% | 6.01% | |
60 Neutral | $1.27B | 76.66 | 1.43% | ― | 10.37% | -73.84% |